Toggle Menu
Join our Community
Support ToI and remove
all
ads
Learn more
English
Français
עברית
Get The Daily Edition
Account
Sign In
Sign in
Join our Community
Open Search form
Toggle Menu
Israel & the Region
Jewish Times
Israel Inside
Tech Israel
Real Estate
Israel
The Blogs
Podcasts
Community
(members only)
Newsletters
The Daily Edition
What Matters Most Today
Tech Israel
Updates from Silicon Wadi
Real Estate Israel
Monthly Update
The Weekend Edition
The Best Reads of the Week
Weekly Highlights
Choice Voices From The Blogs
Partners
Atlanta
Atlanta Jewish Times
North New Jersey
The Jewish Standard
Pittsburgh
Jewish Chronicle
United Kingdom
The Jewish News
Australia
The Australian Jewish News
For Publishers
Become a Partner
Open Search form
Toggle Menu
search
Input search
Clear search input
English
Français
עברית
Latest Articles
Latest Alerts
Israel & the Region
Jewish Times
Israel Inside
Tech Israel
Real Estate
Israel
The Blogs
Podcasts
Community
(members only)
Video
Newsletters
The Daily Edition
What Matters Most Today
Tech Israel
Updates from Silicon Wadi
Real Estate Israel
Monthly Update
The Weekend Edition
The Best Reads of the Week
Weekly Highlights
Choice Voices From The Blogs
Partners
Atlanta
Atlanta Jewish Times
North New Jersey
The Jewish Standard
Pittsburgh
Jewish Chronicle
United Kingdom
The Jewish News
Australia
The Australian Jewish News
For Publishers
Become a Partner
Community
Join our community
Sign in
About The Times of Israel
Advertise on The Times of Israel
Contact us
Download our App
For IOS users
For Android users
Get the Daily Edition
submit
Follow us
© 2026 The Times of Israel , All Rights Reserved
Terms and conditions
Privacy policy
Your Privacy Rights
Input search
Clear search input
Tech Israel
Daily Updates from Silicon Wadi for
Wednesday, January 27, 2021
Facebook
Twitter
View previous edition
View next edition
Sanofi’s $125 million Israeli drug buy could be a three-pronged cancer buster
By
Shoshanna Solomon
Biond Biologics hopes its therapy, which activates 3 separate immune pathways, will prove to be ‘strong and sustained anti-tumor response,’ says CEO; human trials to start mid-2021
Israeli scientists unveil ‘powerful tool’ advancing personalized cancer medicine
By
Nathan Jeffay
12 hours daily screen time: COVID speeds up digitalization of Israeli society
By
Stuart Winer
Annual roundup of internet use by national phone company Bezeq shows users spent an average of 12 hours a day in front of a screen in 2020, as lockdowns kept nation at home
Experts say serology tests unreliable, as immunity doesn’t require antibodies
By
ToI Staff
Facebook gets a ‘D’ from ADL on curbing Holocaust denial
By
PHILISSA CRAMER
Watchdog finds Twitch gaming network is the social media platform most effective at rooting out offending content; YouTube, Twitter and Tiktok get a C
Stepping up efforts, Facebook debuts fact check box to combat Holocaust denial
By
Ron Kampeas
Auschwitz survivor, 92, takes over @Israel for Holocaust Remembrance Day
By
Lazar Berman
YouTube suspends Trump indefinitely, stops Giuliani monetizing clips
By
AFP
Video-sharing giant joins other social media platforms banning former US president over Capitol storming, punishes his lawyer for posting misleading information
Hannah Alberga
My grandfather survived Auschwitz — and spends his life spreading kindness
The rioting mob at the US Capitol shows that hateful ideologies are still alive, but so is he, and against all odds, he has lived a life rooted in love
View Edition by Date
December
January 2021
February
Mo
Tu
We
Th
Fr
Sa
Su
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
The Times of Israel
TECH ISRAEL
FREE, DAILY TO YOUR INBOX
The email is either missing or invalid.
By signing up, you agree to our
terms
You hereby accept The Times of Israel
Terms of Use
and
Privacy Policy
, and you agree to receive the latest news & offers from The Times of Israel and its partners or ad sponsors.
Advertisement
Advertisement
Back to top
Never miss breaking news on Israel
Get notifications to stay updated
Stay updated
No thanks
You're subscribed
close popup
Register for free
and continue reading
Registering allows you to manage your newsletters and alerts and helps us improve your experience. It takes just a few seconds.
Already registered? Enter your email to sign in.
Email address
Please use the following structure: example@domain.com
REGISTER OR SIGN IN
Or Continue with
By registering you agree to the
terms and conditions
. Once registered, you’ll receive our Daily Edition email for free.
Send me The Times of Israel Daily Edition
back
close popup
Register to continue
Email address
Change
REGISTER
Or Continue with
back
close popup
Log in to continue
Email address
Something went wrong.
Please try again in a few minutes..
Continue
back
close popup
Sign in or Register
Email address
*
Password
*
Incorrect password. Please try again or choose an option below.
Continue
I forgot my password
/
Send me a sign in link
Or Continue with
back
close popup
Check your email
We sent an email to you at
.
It has a link that will sign you in.
Click the link in that email to complete your registration.
